Vous n'êtes pas connecté(e)
36
4
Evora Biosciences
Société
à
France
1
abonnés
Onglets principaux
A propos de votre organisation
Evora Biosciences is a biotechnology startup which develops exosomal therapies.
Exosomal therapies are considered to be the next generation of regenerative cell therapies. Indeed, stem cell-derived exosomes exhibit similar therapeutic properties as stem cells, while alleviating several major pain points of cell therapy, mostly logistics- (production, storage, transport) and cost-related.
Evora's lead product, EVOGEX, targets the 50K+ patients treated every year in the US and Europe for complex digestive fistulas. EVOGEX is supported by exciting invivo results, and our goal is to start clinical trials in 2023.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
